BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 20186491)

  • 1. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.
    Tabit CE; Chung WB; Hamburg NM; Vita JA
    Rev Endocr Metab Disord; 2010 Mar; 11(1):61-74. PubMed ID: 20186491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus.
    Tabit CE; Shenouda SM; Holbrook M; Fetterman JL; Kiani S; Frame AA; Kluge MA; Held A; Dohadwala MM; Gokce N; Farb MG; Rosenzweig J; Ruderman N; Vita JA; Hamburg NM
    Circulation; 2013 Jan; 127(1):86-95. PubMed ID: 23204109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endothelial cell dysfunction diabetes mellitus--oxidative stress and cell injury].
    Kashiwagi A
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():216-24. PubMed ID: 12355750
    [No Abstract]   [Full Text] [Related]  

  • 4. Why does diabetes mellitus increase the risk of cardiovascular disease?
    Shahab A
    Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying endothelial dysfunction in diabetes mellitus: therapeutic implications.
    Hink U; Tsilimingas N; Wendt M; Münzel T
    Treat Endocrinol; 2003; 2(5):293-304. PubMed ID: 15981946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in diabetes and hypertension: Role of microRNAs and long non-coding RNAs.
    Zhang HN; Xu QQ; Thakur A; Alfred MO; Chakraborty M; Ghosh A; Yu XB
    Life Sci; 2018 Nov; 213():258-268. PubMed ID: 30342074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eNOS, metabolic syndrome and cardiovascular disease.
    Huang PL
    Trends Endocrinol Metab; 2009 Aug; 20(6):295-302. PubMed ID: 19647446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-protein-coupled receptor kinase 2 and endothelial dysfunction: molecular insights and pathophysiological mechanisms.
    Taguchi K; Matsumoto T; Kobayashi T
    J Smooth Muscle Res; 2015; 51():37-49. PubMed ID: 26447102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction in morbid obesity.
    Mauricio MD; Aldasoro M; Ortega J; Vila JM
    Curr Pharm Des; 2013; 19(32):5718-29. PubMed ID: 23448493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus.
    Endemann DH; Schiffrin EL
    Curr Hypertens Rep; 2004 Apr; 6(2):85-9. PubMed ID: 15010009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-dependent endothelial function and cardiovascular disease.
    Desjardins F; Balligand JL
    Acta Clin Belg; 2006; 61(6):326-34. PubMed ID: 17323842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of endothelial dysfunction in diabetes: role of polyphenols.
    Suganya N; Bhakkiyalakshmi E; Sarada DV; Ramkumar KM
    Br J Nutr; 2016 Jul; 116(2):223-46. PubMed ID: 27264638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial dysfunction in diabetes mellitus and insulin resistance states: role of oxidative stress and potential therapeutic opportunities].
    Schaan BD; Silva AM; Irigoyen MC
    Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):514-5. PubMed ID: 20857055
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling.
    Bretón-Romero R; Feng B; Holbrook M; Farb MG; Fetterman JL; Linder EA; Berk BD; Masaki N; Weisbrod RM; Inagaki E; Gokce N; Fuster JJ; Walsh K; Hamburg NM
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):561-9. PubMed ID: 26800561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus and vascular endothelial dysfunction: current perspectives.
    Tousoulis D; Kampoli AM; Stefanadis C
    Curr Vasc Pharmacol; 2012 Jan; 10(1):19-32. PubMed ID: 22112354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the role of nitric oxide and its clinical applications.
    Levine AB; Punihaole D; Levine TB
    Cardiology; 2012; 122(1):55-68. PubMed ID: 22722323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-linked kinase regulates vasomotor function by preventing endothelial nitric oxide synthase uncoupling: role in atherosclerosis.
    Herranz B; Marquez S; Guijarro B; Aracil E; Aicart-Ramos C; Rodriguez-Crespo I; Serrano I; Rodríguez-Puyol M; Zaragoza C; Saura M
    Circ Res; 2012 Feb; 110(3):439-49. PubMed ID: 22194624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
    Deedwania PC
    Cardiol Clin; 2004 Nov; 22(4):505-9, v. PubMed ID: 15501619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.